In Vitro and In Silico Screening of Benzimidazole-Based Ruthenium(II) Complexes as Potent ALK Inhibitor for Cancer Prevention
-
Published:2023-03-31
Issue:12
Volume:195
Page:7397-7413
-
ISSN:0273-2289
-
Container-title:Applied Biochemistry and Biotechnology
-
language:en
-
Short-container-title:Appl Biochem Biotechnol
Author:
Karthick KamarajORCID, Abinaya Muthukumar, Shankar Thangaraj, Swarnalatha KalaiyarORCID
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,General Medicine,Bioengineering,Biotechnology
Reference40 articles.
1. Cao, B., Bray, F., Ilbawi, A., & Soerjomataram, I. (2018). The Lancet. Global Health., 6, 1288–1296. 2. Arbyn, M., Weiderpass, E., de Bruni, L., Sanjosé, S., Saraiya, M., Ferlay, J., & Bray, F. (2020). The Lancet. Global Health., 8, 191–203. 3. Lionta, E., Spyrou, G. K., Vassilatis, D. & Cournia, Z. (2014). Current Topics In Medicinal Chemistry, 14, 1923–1938. 4. Bennett, J. E., Stevens, G. A., Mathers, C. D., Bonita, R., Rehm, J., Kruk, M. E., & Ezzati, M. (2018). The lancet., 392, 1072–1088. 5. van Rijt, S. H., & Sadler, P. J. (2009). Drug Discovery Today, 14, 1089–1097.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|